Cronos group - The Trending News

Web portal. Search, collect, analyze news, info & data from Internet by ip-www.com

Top News Headlines

Reviewing Cronos Group Inc. (CRON)'s and Adverum Biotechnologies Inc. (NASDAQ:ADVM)'s results
As Biotechnology businesses, Cronos Group Inc. (NASDAQ:CRON) and Adverum Biotechnologies Inc. (NASDAQ:ADVM), are affected by compare.
Aug 15, 2019 22:24 UTC Read More

Reviewing Stemline Therapeutics Inc. (STML)'s and Cronos Group Inc. (NASDAQ:CRON)'s results
Stemline Therapeutics Inc. (NASDAQ:STML) and Cronos Group Inc. (NASDAQ:CRON) compete with each other in the Biotechnology sector. We will analyze…
Aug 15, 2019 10:06 UTC Read More

Apellis Pharmaceuticals Inc. (APLS)'s Financial Results Comparing With Cronos Group Inc. (NASDAQ:CRON)
This is therefore a comparing of the profitability, analyst recommendations, risk, institutional ownership, dividends, earnings and valuation in Apellis.
Aug 14, 2019 22:13 UTC Read More

Contrasting of Cronos Group Inc. (CRON) and Aimmune Therapeutics Inc. (NASDAQ:AIMT)
Both Cronos Group Inc. (NASDAQ:CRON) and Aimmune Therapeutics Inc. (NASDAQ:AIMT) compete on a level playing field in the Biotechnology industry.
Aug 14, 2019 02:18 UTC Read More

Contrasting of Cronos Group Inc. (CRON) and NovaBay Pharmaceuticals Inc. (NYSEAMERICAN:NBY)
We are contrasting Cronos Group Inc. (NASDAQ:CRON) and NovaBay Pharmaceuticals Inc. (NYSEAMERICAN:NBY) on their institutional ownership, earnings…
Aug 13, 2019 00:24 UTC Read More

Contrasting of Cronos Group Inc. (CRON) and Mereo BioPharma Group plc (NASDAQ:MREO)
Both Cronos Group Inc. (NASDAQ:CRON) and Mereo BioPharma Group plc (NASDAQ:MREO) are Biotechnology companies, competing one another. We will…
Aug 12, 2019 22:47 UTC Read More

Brokerages Anticipate Cronos Group Inc (NASDAQ:CRON) to Announce $0.02 Earnings Per Share
Equities research analysts expect Cronos Group Inc (NASDAQ:CRON) to report ($0.02) earnings per share for the current quarter, according to Zacks Investment…
Aug 12, 2019 04:51 UTC Read More

Cronos Group Inc (NASDAQ:CRON) Shares Bought by Flagship Harbor Advisors LLC
Flagship Harbor Advisors LLC grew its holdings in Cronos Group Inc (NASDAQ:CRON) by 290.2% in the second quarter, according to its most recent disclosure…
Aug 11, 2019 16:52 UTC Read More

Cronos Group (NASDAQ:CRON) Upgraded to Buy by Zacks Investment Research
Cronos Group (NASDAQ:CRON) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued on Friday,…
Aug 11, 2019 12:32 UTC Read More

Cronos Group (TSE:CRON) Upgraded at Canaccord Genuity
Cronos Group (TSE:CRON) was upgraded by equities research analysts at Canaccord Genuity from a “sell” rating to a “hold” rating in a research report issued to…
Aug 11, 2019 10:52 UTC Read More

Cronos Group Inc (NASDAQ:CRON) Shares Acquired by Harel Insurance Investments & Financial Services Ltd.
Harel Insurance Investments & Financial Services Ltd. boosted its position in shares of Cronos Group Inc (NASDAQ:CRON) by 100.0% in the 2nd quarter,…
Aug 10, 2019 17:16 UTC Read More

AE Wealth Management LLC Has $254,000 Holdings in Cronos Group Inc (NASDAQ:CRON)
AE Wealth Management LLC boosted its holdings in shares of Cronos Group Inc (NASDAQ:CRON) by 9.7% in the second quarter, according to its most recent…
Aug 10, 2019 13:36 UTC Read More

Bank of America Boosts Cronos Group (NASDAQ:CRON) Price Target to $26.00
Cronos Group (NASDAQ:CRON) had its price target raised by equities research analysts at Bank of America from $20.00 to $26.00 in a note issued to investors…
Aug 10, 2019 11:22 UTC Read More

Why Cronos Group Inc. (CRON) Stock Hammered, Up To 3.2%, in Trade Today
Cronos Group Inc. (NASDAQ:CRON) is among the top losers of the stock market today, sinking -3.2% or (-0.45 points) to $13.44 from its previous close of $13.89…
Aug 09, 2019 19:40 UTC Read More

You Need To Taste this: Cronos Group Inc. (NASDAQ:CRON)
On 09-August 2k19 (Friday), Shareholders tracking shares of Cronos Group Inc. (CRON) belongs to Healthcare sector and Biotechnology industry. CRON…
Aug 09, 2019 18:44 UTC Read More

Buds & Duds: Cannabis stocks stumble on Friday; CannTrust shares sink as auditor withdraws report
Cannabis stocks sank on Friday, as the CannTrust scandal continued to rattle investor confidence in the sector. The North American Marijuana Index, which…
Aug 09, 2019 16:18 UTC Read More

Cronos Group Inc. (CRON): When The Market Gets It Wrong
The stock of Cronos Group Inc. (NASDAQ:CRON) has been Initiated to Equal Weight by Consumer Edge Research in its latest research note that was published…
Aug 09, 2019 15:40 UTC Read More

Lowest Cost, Highest Growth:: Cronos Group Inc., (NASDAQ: CRON)
On Thursday the Cronos Group Inc., (NASDAQ:CRON) belongs to the sector of Healthcare of the Canada. Successful stock market traders and investors don't…
Aug 09, 2019 13:23 UTC Read More

Cronos Group Inc (NASDAQ:CRON) Receives $19.49 Average Target Price from Brokerages
Shares of Cronos Group Inc (NASDAQ:CRON) have been given an average recommendation of “Hold” by the fifteen research firms that are currently covering…
Aug 09, 2019 13:22 UTC Read More

Cronos Group (NASDAQ:CRON) Upgraded at Canaccord Genuity
Cronos Group (NASDAQ:CRON) was upgraded by Canaccord Genuity from a “sell” rating to a “hold” rating in a research report issued to clients and investors on…
Aug 09, 2019 11:35 UTC Read More

$-0.02 EPS Expected for Cronos Group Inc. (CRON)
$-0.02 EPS Expected for Cronos Group Inc. (CRON). Finally, CIBC set a $30.00 target price on shares of Cronos Group and gave the company a "buy" rating in a…
Aug 09, 2019 11:05 UTC Read More

Why Cronos Group Inc. (CRON) Is Down A Whooping 3.24% Today
Cronos Group Inc. (NASDAQ:CRON) is among the top losers of the stock market today, sinking -3.24% or (-0.47 points) to $13.96 from its previous close of…
Aug 08, 2019 18:10 UTC Read More

Giants In The NEWS: Cronos Group Inc. (NASDAQ:CRON)
On 07-August 2k19 (Wednesday), Shareholders tracking shares of Cronos Group Inc. (CRON) belongs to Healthcare sector and Biotechnology industry. CRON…
Aug 08, 2019 13:16 UTC Read More

Cookies

We may use cookies to give you the best experience. If you do nothing we'll assume that it's ok.

Terms & Privacy

The information forward from this site may be provided by third parties. We will not be responsible with outside links, contents from source of information, methods of using, using or consequence of contents with users. All direct or indirect risk related to use of this site is borne entirely by you, the user.

We use advertising companies as Google AdSense, to serve ads when you visit our website. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements about goods and services of interest to you. If you would like more information about this practice and to know your choices about not having this information used by these companies, see https://policies.google.com/technologies/ads.